Clinical Trials Logo
  1. Home
  2. Metabolic Disorders
  3. NCT02107872

Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500

Metabolic Disorders Clinical Trial

Clinical Trial Summary

This is a phase 1, randomized, double-blind, placebo-controlled, multiple ascending dose study to assess the safety, tolerability, pharmacokinetic (PK), immunogenicity, and pharmacodynamic (PD) effects of REGN1500 in patients with a metabolic disorder.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02107872
Study type Interventional
Source Regeneron Pharmaceuticals
Contact
Status Completed
Phase Phase 1
Start date April 2014
Completion date September 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT02311270 - Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation N/A
Completed NCT02039596 - Nutritional Metabolomics: the Search for Dietary Exposure Variables N/A
Completed NCT04142424 - A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects Phase 1
Recruiting NCT05398783 - A Natural History Study of Metabolic Sizing in Health and Disease
Completed NCT00387166 - Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American Women N/A
Completed NCT02130908 - A Study on the Possible Health Effects of Lean Fish, Fatty Fish and Lean Meat Intake in Non-obese Adults N/A
Recruiting NCT03128996 - Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders Phase 1/Phase 2
Terminated NCT02354443 - A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders Phase 1
Not yet recruiting NCT06358118 - Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders N/A
Recruiting NCT02503384 - Clinical and Basic Study for Pediatric Liver Transplantation N/A
Active, not recruiting NCT01894139 - An Optimized Programming of Healthy Children (APPROACH) N/A
Completed NCT04868240 - Concurrent Training and Metabolic Profile, Lung Function, Quality of Life and Stress N/A
Terminated NCT02231710 - Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases Phase 1
Recruiting NCT00920972 - Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases Phase 1/Phase 2
Active, not recruiting NCT03188107 - Interrater Reliability of Infant Motor Profile N/A
Withdrawn NCT03284658 - Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)
Completed NCT06067126 - Post-delivery Maternal-offspring Obesity and Metabolic Risk After a Prepregnancy Weight-loss Intervention
Recruiting NCT02419898 - Oxfordshire Women and Their Children's Health
Terminated NCT01343680 - Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients Phase 3